These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33765581)

  • 1. Epilobium angustifolium L. extract with high content in oenothein B on benign prostatic hyperplasia: A monocentric, randomized, double-blind, placebo-controlled clinical trial.
    Esposito C; Santarcangelo C; Masselli R; Buonomo G; Nicotra G; Insolia V; D'Avino M; Caruso G; Buonomo AR; Sacchi R; Sommella E; Campiglia P; Tenore GC; Daglia M
    Biomed Pharmacother; 2021 Jun; 138():111414. PubMed ID: 33765581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the therapeutic effect against benign prostatic hyperplasia and the active constituents from Epilobium angustifolium L.
    Deng L; Zong W; Tao X; Liu S; Feng Z; Lin Y; Liao Z; Chen M
    J Ethnopharmacol; 2019 Mar; 232():1-10. PubMed ID: 30529422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Effect of Epilobium angustifolium Aqueous Extract on LNCaP Cell Proliferation in In Vitro and In Vivo Models.
    Piwowarski JP; Bobrowska-Korczak B; Stanisławska I; Bielecki W; Wrzesien R; Granica S; Krupa K; Kiss AK
    Planta Med; 2017 Oct; 83(14-15):1159-1168. PubMed ID: 28454190
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of the effect of Epilobium extracts on human cell proliferation.
    Vitalone A; McColl J; Thome D; Costa LG; Tita B
    Pharmacology; 2003 Oct; 69(2):79-87. PubMed ID: 12928581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II randomised double-blind placebo-controlled clinical trial investigating the efficacy and safety of ProstateEZE Max: a herbal medicine preparation for the management of symptoms of benign prostatic hypertrophy.
    Coulson S; Rao A; Beck SL; Steels E; Gramotnev H; Vitetta L
    Complement Ther Med; 2013 Jun; 21(3):172-9. PubMed ID: 23642948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of different natural extracts in an experimental model of benign prostatic hyperplasia (BPH).
    Paterniti I; Campolo M; Cordaro M; Siracusa R; Filippone A; Esposito E; Cuzzocrea S
    Inflamm Res; 2018 Jul; 67(7):617-626. PubMed ID: 29679313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ageratum conyzoides L. inhibits 5-alpha-reductase gene expression in human prostate cells and reduces symptoms of benign prostatic hypertrophy in otherwise healthy men in a double blind randomized placebo controlled clinical study.
    Detering M; Steels E; Koyyalamudi SR; Allifranchini E; Bocchietto E; Vitetta L
    Biofactors; 2017 Nov; 43(6):789-800. PubMed ID: 29048765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A two-week, double-blind, placebo-controlled trial of Viola odorata, Echium amoenum and Physalis alkekengi mixture in symptomatic benign prostate hyperplasia (BPH) men.
    Beiraghdar F; Einollahi B; Ghadyani A; Panahi Y; Hadjiakhoondi A; Vazirian M; Salarytabar A; Darvishi B
    Pharm Biol; 2017 Dec; 55(1):1800-1805. PubMed ID: 28532232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Murraya koenigii- and Tribulus terrestris-based oral formulation versus tamsulosin in the treatment of benign prostatic hyperplasia in men aged >50 years: a double-blind, double-dummy, randomized controlled trial.
    Sengupta G; Hazra A; Kundu A; Ghosh A
    Clin Ther; 2011 Dec; 33(12):1943-52. PubMed ID: 22177370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic profiling, in vitro bioaccessibility and in vivo bioavailability of a commercial bioactive Epilobium angustifolium L. extract.
    Dacrema M; Sommella E; Santarcangelo C; Bruno B; Marano MG; Insolia V; Saviano A; Campiglia P; Stornaiuolo M; Daglia M
    Biomed Pharmacother; 2020 Nov; 131():110670. PubMed ID: 32896677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicentric, placebo-controlled, double-blind clinical trial of beta-sitosterol (phytosterol) for the treatment of benign prostatic hyperplasia. German BPH-Phyto Study group.
    Klippel KF; Hiltl DM; Schipp B
    Br J Urol; 1997 Sep; 80(3):427-32. PubMed ID: 9313662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Medium-to-long-term Use of Tolterodine Extended Release with or without Tamsulosin in Patients with Benign Prostate Hyperplasia and Larger Prostate Size: A Double-blind, Placebo-controlled, Randomized Clinical Trial.
    Cai JL; Zhou Z; Yang Y; Yan YF; Jing S; Na YQ
    Chin Med J (Engl); 2016 Dec; 129(24):2899-2906. PubMed ID: 27958220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urtica dioica for treatment of benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled, crossover study.
    Safarinejad MR
    J Herb Pharmacother; 2005; 5(4):1-11. PubMed ID: 16635963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double blind, placebo-controlled randomized comparative study on the efficacy of phytosterol-enriched and conventional saw palmetto oil in mitigating benign prostate hyperplasia and androgen deficiency.
    Sudeep HV; Thomas JV; Shyamprasad K
    BMC Urol; 2020 Jul; 20(1):86. PubMed ID: 32620155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
    Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
    BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamsulosin efficiency in treatment of benign prostatic hyperplasia evaluated by determining bladder weight.
    Milicevic S
    Med Arch; 2012; 66(6):391-5. PubMed ID: 23409519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phytochemistry, pharmacology and traditional uses of different Epilobium species (Onagraceae): a review.
    Granica S; Piwowarski JP; Czerwińska ME; Kiss AK
    J Ethnopharmacol; 2014 Oct; 156():316-46. PubMed ID: 25196824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Serenoa repens Extract Among Patients with Benign Prostatic Hyperplasia in China: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial.
    Ye Z; Huang J; Zhou L; Chen S; Wang Z; Ma L; Wang D; Wang G; Wang S; Liang C; Qiu S; Gu X; Liu J; Weng Z; Wu C; Wei Q; Xie L; Wu W; Cheng Y; Hu J; Wang Z; Zeng X
    Urology; 2019 Jul; 129():172-179. PubMed ID: 30880074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pumpkin seed in men with lower urinary tract symptoms due to benign prostatic hyperplasia in the one-year, randomized, placebo-controlled GRANU study.
    Vahlensieck W; Theurer C; Pfitzer E; Patz B; Banik N; Engelmann U
    Urol Int; 2015; 94(3):286-95. PubMed ID: 25196580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Adding Dutasteride to α-Blocker Therapy Treated Benign Prostatic Hyperplasia Patients with Small Volume Prostate (<30 mL).
    Hashimoto M; Shimizu N; Sugimoto K; Hongoh S; Minami T; Nozawa M; Yoshimura K; Hirayama A; Tahara H; Uemura H
    Low Urin Tract Symptoms; 2017 Sep; 9(3):157-160. PubMed ID: 26991643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.